Maternal antiretroviral drugs during pregnancy and infant low birth weight and preterm birth.

@article{Szyld2006MaternalAD,
  title={Maternal antiretroviral drugs during pregnancy and infant low birth weight and preterm birth.},
  author={Edgardo G Szyld and Eduardo M Warley and Laura Freimanis and Ren{\'e} Gonin and Pedro E. Cahn and Guilherme Amaral Calvet and Geraldo Duarte and Victor Hugo Cunha de Melo and Jennifer Suzanne Read},
  journal={AIDS},
  year={2006},
  volume={20 18},
  pages={2345-53}
}
OBJECTIVE To determine the relationship between maternal antiretroviral regimens during pregnancy and adverse infant outcomes [low birth weight (LBW) and preterm birth]. The a priori hypothesis was that protease inhibitor (PI)-containing regimens are associated with an increased risk of LBW and preterm birth. DESIGN Prospective cohort study of HIV-1-infected women and their infants (NISDI Perinatal Study). METHODS Data were analysed from 681 women receiving at least one antiretroviral drug… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 43 extracted citations

Similar Papers

Loading similar papers…